STI-571: current status and future prospects. | Curr Opin Investig Drugs;2(9): 1279-81, 2001 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

STI-571: current status and future prospects.

Schiffer, C A.

Affiliation

Schiffer CA; Karmanos Cancer Institute, Wayne State University School of Medicine, Harper Hospital, 505 Hudson, 3990 John R, Detroit, MI 48201, USA. schiffer@karmanos.org

Curr Opin Investig Drugs ; 2(9): 1279-81, 2001 Sep.

Article in En | MEDLINE | ID: mdl-11717816

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Curr Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Curr Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2001 Document type: Article Affiliation country: Country of publication: